partners

We believe in long-term cooperation

As a family-owned company, we value trust and reliability. Together with our partners – many of whom are long-term collaborators – we develop products and solutions that will meet the needs of markets and patients – today and tomorrow.

The healthcare market is changing at an incredibly rapid pace. We want our partners to be a step ahead.

Berlin-Chemie

Berlin-Chemie is a German subsidiary of the MENARINI Group, which has been occupying a leading position in the Italian pharmaceutical market for many years. The company, which was founded in 1886 and is headquartered in Florence, has developed over several generations to become a global, owner-managed pharmaceutical company.

Dong-A Pharm.Co.LTD

Dong-A Pharmaceutical is a company driven by its core values. The enterprise works hard every day to follow its commitment to integrity, excellence and respect for humanity in everything that it does. In other words: working for a better tomorrow.

Ferring Pharmaceuticals

Ferring's specialists believe in the power of research and the need to go where the research takes them. Ferring believes in the value of partnership and of sharing knowledge. The company are passionate and curious about science.

Merck

Merck has three businesses: Healthcare, Life Science and Performance Materials. The Healthcare business is a leader in specialty pharma markets and boasts a global footprint, a strong presence in emerging markets and solid pipeline assets. The Medical Devices franchise is headquartered in Coinsins, Switzerland. The group of companies affiliated with Merck KGaA (Darmstadt, Germany) only operate under individual business names in the United States and Canada (EMD Serono, MilliporeSigma, EMD Performance Materials).

Sanofi

Innovation is a main driver of Sanofi's transformation into a diversified global leader focused on patient needs. This is why the company seeks breakthrough innovations wherever they are found, such as universities, research centers, biotech companies and venture capital portfolios – across all corners of the globe.

Shire

Shire enables people with life-altering conditions to lead better lives. The company focuses on developing and delivering innovative medicines for patients with rare diseases and other specialty conditions. This might be a therapy to treat an extremely rare and life-threatening disease such as Hunter syndrome or Fabry disease, or a medicine for a specialist condition such as ADHD or ulcerative colitis.